HOME >> BIOLOGY >> NEWS
'Plants for the future': A European vision for plant biotechnology towards 2025

Today, the "Plants for the Future" European Technology Platform on plant genomics and biotechnology, launches a new era for plant biotechnology in Europe.

This long term vision for 2025 has been created by leading representatives from research (such as EPSO, the European Plant Science Organisation), the food and biotech industry (such as EuropaBio, CIAA, ESA), the farming community (such as COPA/COGECA) and consumer organisations (BEUC). The vision document has been presented to European Commissioner Busquin.

"Our society faces tremendous challenges in the coming decades. There will be an increased demand for healthier, higher quality and more diverse food. The need for animal feed will grow. Agricultural production needs to become more environmentally friendly: maintaining productivity while reducing inputs including water, pesticides, fertilisers, energy. The issue of economical sustainability will necessitate the development of novel biomaterials, bioenergy and renewable resources. Agriculture will also face consequences of climatic changes causing drought and spread of diseases to new areas of Europe and beyond. It is imperative that we enable developing countries to achieve self-sufficiency and become more competitive and, together with North America, to contribute to meeting the growing global food demands," says Marc Zabeau, chair of EPSO.

These immense challenges can be met by prioritizing basic and applied research goals that are tailored to the needs of European society and the agriculture and the food industries. The expertise and capabilities of European plant scientists also need to be effectively harnessed to generate a more profound understanding of plant biology. Together this new set of capabilities and priorities will enable key characteristics such as improved quality and nutrition, sustainable production, safe co-existence, and improved yield, harvestability, processability and environmental stability to be created, Nove
'"/>

Contact: Karin Metzlaff
Karin.Metzlaff@psb.ugent.be
0032-9-331-3810
VIB, Flanders Interuniversity Institute of Biotechnology
24-Jun-2004


Page: 1 2

Related biology news :

1. European common frog found to use novel mating strategy
2. Zoonotic diseases - European scientists unite to fight diseases
3. Second call for proposals for the European Young Investigator Award
4. Common call for action on European Research Council (ERC)
5. EURYI Award given for the first time to 25 young European researchers
6. European researchers tackle mitosis
7. Key principles for the foundation of a European Research Council (ERC)
8. EC boosts European electron microscopy research
9. European Commission approves Herceptin + Taxotere as 1st-line therapy in HER2-positive breast cancer
10. Limited climate tracking in European trees despite 10,000 years of postglacial warmth
11. ESA consults European science community on candidate Earth Explorer missions

Post Your Comments:
(Date:7/21/2015)... , July 21, 2015  NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile ... wallet, announces that it has filed provisional patent ... Method. This invention highlights next ... authorizes an account, but also the user using ...
(Date:7/13/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... on the growing mobile commerce market, announced today ... BEHAVIORAL-DIRECTED AUTHENTIATION METHOD AND SYSTEM. ... method to make payments.  With this patent, NXT-ID ... its groundbreaking voice-direct payment patent application, with behavior-directed ...
(Date:7/9/2015)... Calif. , July 9, 2015 /PRNewswire/ ... leading developer of human interface solutions, today ... the industry,s first fully hardware encapsulated fingerprint ... secure authentication technology is literally off the ... and biometric matching within the fingerprint sensor ...
Breaking Biology News(10 mins):NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3
(Date:7/31/2015)... ... July 31, 2015 , ... Global ... and premium industry insights on the global resorcinol industry. The report highlights the ... of vivid market scenarios and analysis of primary and secondary inputs from the ...
(Date:7/30/2015)... , July 30, 2015   GenoSpace ... for the interpretation and analysis of genomic and ... Fischer has joined the company as Vice ... - http://photos.prnewswire.com/prnh/20150730/250931 "GenoSpace ... to integrate, interpret, analyze and explore complex sets ...
(Date:7/30/2015)... 30, 2015   Aratana Therapeutics, Inc . ... focused on the licensing, development and commercialization of ... that its strategic partner VetStem Biopharma, Inc. has ... of AT-016, an adipose-derived allogeneic stem cell product ... osteoarthritis pain in dogs. The double-blinded, ...
(Date:7/30/2015)... 2015  Discovery Laboratories, Inc. (Nasdaq: DSCO ... second $1.0M tranche under a previously awarded Phase ... at up to $3.0 million to support continued ... a potential medical countermeasure to mitigate acute and ... an initial $1.0 million under this grant in ...
Breaking Biology Technology:Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 2Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 3Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 4GenoSpace Introduces Matthew Fischer as Vice President of Sales and Marketing 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 5Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3
Cached News: